公司資料
Centessa Pharmaceuticals 股價、新聞與催化劑
- 股票代碼:
- CNTA
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United Kingdom
股票表現
40.50 USD (+0.80%)
收盤價
最後更新: 2026年6月23日
6.17B USD
市值
股價為何變動
Current closing-price context is not available for CNTA.
公司概覽
業務概覽
Centessa Pharmaceuticals is a platform biopharma company incubating focused therapeutic programs across multiple disease areas. Its model emphasizes capital allocation, program selection, and broad platform optionality.
所在地與產業分類
Headquartered in the United Kingdom and listed on NASDAQ as an ADR, Centessa has a global specialty-biopharma profile.
商業模式特徵
The company depends on pipeline prioritization, clinical validation, and the ability to unlock value from multiple programs.
生技產業定位
Centessa is a platform biotech name whose valuation reflects optionality and execution across a portfolio of assets.
未來催化劑
- Centessa’s catalyst set is ORX750 and the broader orexin-agonist strategy, which could matter a lot if the sleep program continues to show a clean dose and efficacy profile. The next update is important because the market wants to know whether the orexin thesis can become a real franchise.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。